Retirement Plan Consolidation for Manufacturing Company

We represented a publically-traded manufacturing company in the consolidation of three pension plans and three 401(k) plans following its $1.4 billion acquisition of another company. The plans had combined assets in excess of $2 billion, each with different benefit formulas and service providers. We ran two separate RFP processes designed to harmonize retirement benefits between the two companies. We collected and evaluated potential vendors, negotiated all service agreements with the new vendor, terminated the existing service providers, engaged a new investment advisor and an investment transfer fiduciary to oversee the investment migration, and established new trusts and plan documents as well as governance documents needed for the prudent discharge of duties by the plan’s fiduciaries. The RFP processes have resulted in a dramatic improvement in the quality of services provided and are expected to save our client approximately $6.5 million over a two year period.

You Also May Be Interested In:

  • Representing Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their agreement to be acquired by funds managed by Stone Point Capital, with over $40 billion of assets under management; under the terms of the agreement, Tivity Health stockholders will receive $32.50 in cash per share, representing a total transaction value of $2.0 billion

    We are representing Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their agreement to be...
    Client Type: Public Company
  • We represented a home healthcare provider in their purchase of a company partially owned by an Employee Stock Ownership Plan (ESOP).

    We represented a home healthcare provider in their purchase of a company partially owned by an Employee Stock Ownership Plan...
    Client Type: Private Company
  • Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management.  Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.

    We served as lead legal counsel to POINT Biopharma Inc., a late stage biopharmaceutical company dedicated to bringing the many...
    Client Type: Private Company